SION

Sionna Therapeutics, Inc.

Sales chart range
Log in to watch SION
Latest sale
$21.8M
Sep 17 · Unusual
Form 4 sales
42
On record
Form 144 notices
0
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    May 27 2026

    Sold 101 shares at $44.49 ($4k)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 0% of holdings ($119M position)2.7M shares left0x usual sizeFiling

  2. 2 Form 4 saleRoutine
    May 27 same day

    Sold 101 shares at $44.49 ($4k)

    Thompson Peter A., Director

    10b5-1 planSold 0% of holdings ($119M position)2.7M shares left0x usual sizeFiling

  3. 3 Form 4 saleRoutine
    Jun 30 +34 days

    Sold 115,844 shares at $45.50 ($5.3M)

    Orbimed Advisors LLC, Director

    10b5-1 planSold 4.3% of holdings ($122M position)2.6M shares left1.1x usual sizeFiling

  4. 4 Form 4 saleRoutine
    Jun 30 same day

    Sold 115,844 shares at $45.50 ($5.3M)

    Thompson Peter A., Director

    10b5-1 planSold 4.3% of holdings ($122M position)2.6M shares left2.6x usual sizeFiling

  5. 5 Form 4 saleRoutine
    Jul 6 +6 days

    Sold 10,250 shares at $43.60 ($447k)

    Fitzpatrick Jennifer, Chief Legal Officer

    10b5-1 planSold 100% of holdings ($447k position)0 shares left1x usual sizeFiling

  6. 6 Form 4 saleRoutine
    Jul 7 +1 day

    Sold 85,918 shares at $44.86 ($3.9M)

    OrbiMed Capital GP VIII LLC, Director

    10b5-1 planSold 3.4% of holdings ($115M position)2.5M shares left2.8x usual sizeFiling

  7. 7 Form 4 saleRoutine
    Jul 7 same day

    Sold 85,918 shares at $44.86 ($3.9M)

    Thompson Peter A., Director

    10b5-1 planSold 3.4% of holdings ($115M position)2.5M shares left1.6x usual sizeFiling

  8. 8 Form 4 saleUnusual
    Sep 17 +72 days

    Sold 3.4M shares at $6.33 ($21.8M)

    Ra Capital Management, L.P., Director, 10% owner

    No 10b5-1 planSold 50% of holdings ($43.7M position)3.4M shares leftFiling

Every transaction

Loading transactions…

Sales, notices and lockups (42)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for SION
Source
Sep 17, 2026Ra Capital Management, L.P.Director, 10% ownerForm 4 sale3.4M$21.8M50.0%UnusualSEC
Jul 7, 2026Thompson Peter A.DirectorForm 4 sale85,918$3.9M3.4%RoutineSEC
Jul 7, 2026OrbiMed Capital GP VIII LLCDirectorForm 4 sale85,918$3.9M3.4%RoutineSEC
Jul 6, 2026Fitzpatrick JenniferChief Legal OfficerForm 4 sale10,250$447k100.0%RoutineSEC
Jun 30, 2026Thompson Peter A.DirectorForm 4 sale115,844$5.3M4.3%RoutineSEC
Jun 30, 2026Orbimed Advisors LLCDirectorForm 4 sale115,844$5.3M4.3%RoutineSEC
May 27, 2026Thompson Peter A.DirectorForm 4 sale101$4k0.0%RoutineSEC
May 27, 2026Orbimed Advisors LLCDirectorForm 4 sale101$4k0.0%RoutineSEC
May 11, 2026Thompson Peter A.DirectorForm 4 sale292,952$13.4M9.9%UnusualSEC
May 11, 2026Orbimed Advisors LLCDirectorForm 4 sale292,952$13.4M9.9%RoutineSEC
Apr 18, 2026Thompson Peter A.DirectorForm 4 sale55,345$2.5M1.8%RoutineSEC
Apr 18, 2026Orbimed Advisors LLCDirectorForm 4 sale55,345$2.5M1.8%RoutineSEC
Apr 16, 2026Thompson Peter A.DirectorForm 4 sale510,583$22.9M14.5%UnusualSEC
Apr 16, 2026Orbimed Advisors LLCDirectorForm 4 sale510,583$22.9M14.5%RoutineSEC
Mar 5, 2026Fitzpatrick JenniferChief Legal OfficerForm 4 sale10,250$347k100.0%RoutineSEC
Feb 3, 2026Thompson Peter A.DirectorForm 4 sale30,953$1.4M0.9%RoutineSEC
Feb 3, 2026OrbiMed Capital GP VIII LLCDirectorForm 4 sale30,953$1.4M0.9%RoutineSEC
Jan 22, 2026Winkelried Jon10% ownerForm 4 sale250,000$10M3.7%No planSEC
Dec 24, 2025OrbiMed Capital GP VIII LLCDirectorForm 4 sale33,356$1.5M0.9%RoutineSEC
Dec 24, 2025Thompson Peter A.DirectorForm 4 sale33,356$1.5M0.9%RoutineSEC
Dec 19, 2025OrbiMed Capital GP VIII LLCDirectorForm 4 sale1,875$83k0.1%RoutineSEC
Dec 19, 2025Thompson Peter A.DirectorForm 4 sale1,875$83k0.1%RoutineSEC
Dec 5, 2025Fitzpatrick JenniferChief Legal OfficerForm 4 sale10,250$415k100.0%RoutineSEC
Nov 26, 2025Orbimed Advisors LLCDirectorForm 4 sale108,073$4.8M2.9%RoutineSEC
Nov 26, 2025Thompson Peter A.DirectorForm 4 sale108,073$4.8M2.9%RoutineSEC
Nov 21, 2025Kolchinsky PeterDirector, 10% ownerForm 4 sale30,316$1.2M16.0%No planSEC
Nov 19, 2025Ra Capital Management, L.P.Director, 10% ownerForm 4 sale136,351$5.5M44.8%UnusualSEC
Oct 28, 2025RA Capital Nexus Fund III, L.P.DirectorForm 4 sale373,610$14.8M64.1%UnusualSEC
Oct 21, 2025Cloonan MichaelPresident & CEOForm 4 sale99,800$3.6M15.4%UnusualSEC
Oct 21, 2025Booth BruceDirectorForm 4 sale88,878$3M11.5%RoutineSEC
Oct 20, 2025Booth BruceDirectorForm 4 sale286,369$9.3M29.0%UnusualSEC
Oct 16, 2025Cloonan MichaelPresident & CEOForm 4 sale25,200$788k4.4%RoutineSEC
Oct 15, 2025Booth BruceDirectorForm 4 sale194,932$5.9M20.6%RoutineSEC
Oct 6, 2025Booth BruceDirectorForm 4 sale49,546$1.5M5.9%RoutineSEC
Oct 1, 2025Booth BruceDirectorForm 4 sale78,693$2.4M9.0%RoutineSEC
Sep 29, 2025Cloonan MichaelPresident & CEOForm 4 sale25,000$728k4.4%RoutineSEC
Sep 4, 2025Fitzpatrick JenniferChief Legal OfficerForm 4 sale10,250$237k100.0%RoutineSEC
Sep 2, 2025Ridloff ElenaCFO & Head of Corp. Dev.Form 4 sale9,584$240k19.9%RoutineSEC
Aug 28, 2025Ridloff ElenaCFO & Head of Corp. Dev.Form 4 sale23,416$602k32.7%RoutineSEC
Aug 27, 2025Cloonan MichaelPresident & CEOForm 4 sale25,000$624k4.4%RoutineSEC
Aug 20, 2025Cloonan MichaelPresident & CEOForm 4 sale25,000$569k4.4%RoutineSEC
Aug 20, 2025Ridloff ElenaCFO & Head of Corp. Dev.Form 4 sale52,000$1.1M42.1%RoutineSEC